BioSpace News Archive

Business

Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update

Histogen Inc. announced that Histogen’s financial results for the second quarter ended June 30, 2022 will be released after the close of market on Thursday, August 11, 2022.

July 27, 2022
·
1 min read
Genetown

Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement

Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatological products, announced it has entered into agreements with certain of its holders of its existing warrants for 2,857,143 shares of its common stock, in the aggregate.

July 27, 2022
·
4 min read
Pharm Country

An Exclusive New Level of Data Comes to Healthcare Monitoring

Exclugo, the healthcare industry’s provider of “fresher healthcare monitoring,” is pleased to announce a breakthrough in the monitoring of sexual predators seeking employment within the healthcare industry.

July 27, 2022
·
2 min read
Business

Concarlo Therapeutics Hires Vadim Shepel as Chief Business & Operating Officer, Completing Build-out of Company’s Core Executive Team

Concarlo Therapeutics has hired Vadim Shepel as Chief Business & Operating Officer.

July 27, 2022
·
4 min read
Biotech Bay

Empowering Tomorrow’s Great Minds in Cancer Research: The Parker Institute for Cancer Immunotherapy Awards up to $4.5 Million to Nine Early Career Researchers; Total of Over $19 Million Awarded to Date

The Parker Institute for Cancer Immunotherapy is helping to forge a future without cancer, by investing in ’s top talent to train and empower the research leaders of tomorrow.

July 27, 2022
·
6 min read
NuGen M.D. Commences Trading on OTCQB Under The Symbol ‘NGMDF’

NuGen Medical Devices Inc., a leader in needle-free drug delivery, is pleased to announce that, effective July 27, 2022, its common shares will commence trading on the OTCQB under the symbol NGMDF.

July 27, 2022
·
2 min read
Creative Biogene Provides High-quality Transfection Reagents to Deliver mRNA in A Variety of Cells

Recently, Creative Biogene announced the release of its high quality transfection reagents which can be applie to deliver mRNA in a variety of cells or in vivo.

July 27, 2022
·
2 min read
Co-Diagnostics, Inc. to Participate in Yale University SalivaDirect™ Conference Held July 28-29 in Chicago

Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or the “Company”), announced today that it will be attending and speaking at the Yale School of Public Health SalivaDirect™ Conference held July 28-29 in Chicago, Il.

July 27, 2022
·
1 min read
BioMidwest

BIO 300 Pharmacokinetics Studies Published

A recently published paper in Radiation Research, the official journal of the Radiation Research Society, details the results from a series of pharmacokinetics studies conducted with Humanetics Corporation’s new radioprotective drug, BIO 300.

July 27, 2022
·
2 min read
Novel Cancer Immunotherapy Clinical Trials Emerging Trends

Targeted therapies such as immunotherapy harness the potential of immune system to selectively target the cancer cells.

July 27, 2022
·
5 min read